with a focus on the clinical and economic implications for rehospitalization. Hospitalization and Mortality Associated With Worsening Heart Failure It is not uncommon for patients with worsening ...

ALLHAT was a large, simple trial, designed in a fashion to closely mimic clinical practice as it ... This finding was largely driven by congestive heart failure. The practicing clinician should ...

A research team in the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) ...

The new approach is designed to create a connection between the left and right atrial chambers of the heart in a single ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...

Watt said, “Heart failure remains an urgent, unmet clinical challenge across the world. While we have made significant advances over several decades in managing the disease, we lack targeted ...

But if the gene therapy shows similar results in future clinical trials, it could help heal the hearts of the 1 in 4 people alive today who will eventually develop heart failure. A "night and day ...

The heart failure market is projected to grow from $13.5 billion in 2022 to $33.7 billion by 2032, driven by new therapies, ...

“It’s exciting to see innovation is still happening,” said Dr. Mani Daneshmand, an Emory cardiothoracic surgeon leading the clinical ... for patients with heart failure who are not ...

Faun1083 has demonstrated positive in-vivo efficacy in multiple preclinical animal models, including rat sugen hypoxia and ...